Caloric restriction — reducing caloric intake by 20–40% without malnutrition — is the most reproducible intervention for extending lifespan across virtually every model organism tested. Its mechanisms overlap significantly with fasting and represent a key pathway to longevity research.
What Does the Research Say?
Caloric restriction extends lifespan in yeast, worms, flies, mice, and rats by 30–100% depending on species and timing. In non-human primates, two major studies (Wisconsin and NIA) showed mixed overall survival outcomes but consistent improvements in healthspan — reduced cancer, diabetes, and cardiovascular disease across the board.
The CALERIE trial in humans reduced multiple aging biomarkers over 2 years with just 12% average caloric restriction, including reductions in thyroid hormones consistent with a slower metabolic rate, inflammatory markers, and insulin resistance. CR’s benefits are mediated through AMPK activation, mTOR inhibition, sirtuins, and improved insulin sensitivity — pathways that converge on cellular quality control.
Key Findings
- Most reproducible longevity intervention across model organisms including primates
- Consistently reduces age-related disease (cancer, cardiovascular, diabetes) even in non-obese subjects
- Human CALERIE trial confirmed meaningful biomarker improvements with modest 12% CR
- Mechanisms overlap with and potentiate fasting, exercise, and longevity pharmacology
Practical Takeaway
Long-term strict caloric restriction is difficult to sustain and may reduce muscle and bone density if protein is not prioritized. A practical approach: target 10–15% below estimated energy needs with high protein intake and resistance training, rather than aggressive restriction. CR is most beneficial when micronutrient adequacy is fully maintained.